MODIFIED INGAP PEPTIDES FOR TREATING DIABETES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jan 7, 2016
app pub date -
Feb 14, 2014
filing date -
Feb 15, 2013
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Calculated Rating
|
US Family Size
|
Non-US Coverage
|
Abstract
Novel INGAP peptides for prevention or treatment of diabetes are provided herein, as well as compositions and methods of use thereof. In particular, a 19 amino acid peptide of INGAP which possesses β-cell neogenesis and insulin potentiating activities and is sufficiently stable for in vivo use is described.
First Claim
Other Claims data not available
Family
+
−
| Country | kind | publication No. | Filing Date |
|---|---|---|---|
| CA | A1 | CA2901404 | Feb 14, 2014 |
| WO | A1 | WO2014124540 | Feb 14, 2014 |
| JP | A | JP2016508509 | Feb 14, 2014 |
| EP | A1 | EP2956475 | Feb 14, 2014 |
| CN | A | CN105492459 | Feb 14, 2014 |
International Classification(s)
- 2014 Application Filing Year
- A61K Class
- 14144 Applications Filed
- 11600 Patents Issued To-Date
- 82.02 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 4 Citation Count
- A61K Class
- 38.16 % this patent is cited more than
- 9 Age